FDA finalizes AI-enabled medical device life cycle plan guidance

The U.S. Food and Drug Administration has announced the availability of its final guidance on AI medical devices. 

The document – Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions – aims to provide a “forward-thinking approach to promote the development of safe and effective AI-enabled devices,” the agency said in a statement Tuesday.

WHY IT…